The Hospital Company of the Hills confirms its leadership in the treatment of respiratory diseases with the activation, in the clinical biochemistry laboratory of the Monaldi hospital, of the procedure to diagnose the Alpha-1-antitrypsin deficiency, a rare respiratory disease that, if not adequately treated, leads to a serious impairment of the respiratory system with the onset of emphysema, chronic obstructive bronchopathy, adult asthma and, in very serious cases, can lead the patient to a lung transplant.
The liver is also involved in clinical manifestations, from chronic liver disease to cirrhosis, up to liver transplant. The Hospital Company of the Hills is a reference center for the treatment of this disease and the Monaldi Laboratory is the third active national center in Italy, the first in Campania, capable of performing this particular examination. Early diagnosis is fundamental because appropriate therapy, namely the administration of a replacement therapy, changes the natural history of the disease, interfering with the clinical-functional decline that people affected by Alpha-1-antitrypsin deficiency undergo.
In case of suspicion, therefore, it will be possible to proceed with the diagnostic tests by sending the samples directly to the Hospital Company of the Hills thanks to the use of a pre-established Kit that uses the Dried Blood Spot (DBS), this consists of taking a few drops of blood that are fixed on the paper filter of the Kit, which is then sent by regular mail to the Clinical Biochemistry Laboratory of Monaldi.
A structure among the most advanced in Central-Southern Italy, equipped with ultra-modern equipment that performs about 3 million examinations every year thanks to the use of a state-of-the-art automation system. 'With this further step forward we complete the diagnosis of a rare and highly disabling disease.'
The Hospital Company of the Hills, with the Monaldi Hospital, has a cardiopulmonary vocation that makes us one of the most attractive centers for the treatment of these diseases. Only in 2022, hundreds of people from other regions have turned to our structure for pulmonary and respiratory diseases' is the comment of Anna Iervolino, general manager of the Hospital Company of the Hills.